3 tracked public figures made calls on MRK. We grade SELL/REDUCE calls as Correct/Incorrect/Pending, and compare BUY/ADD returns against the S&P 500 over matched windows.
On average, public BUY calls on Merck beat the S&P 500 by +3.4%.
| Who | Signal | Date | Return / Grade | Buy vs S&P | Source |
|---|---|---|---|---|---|
| Lori Calvasina | BUY | Feb 26, 2026 | -4.3% | -5.9% | source ↗ |
| Charlie Scharf | BUY | Mar 12, 2026 | -1.5% | -2.6% | source ↗ |
| Joe Terranova | BUY | Feb 02, 2026 | +0.7% | -6.7% | source ↗ |
Joe Terranova currently ranks #1 on MRK with +0.7% average buy return vs -6.7% for the S&P 500 (+7.5% alpha) across 1 scored buy calls.
Yes. Across 3 scored BUY/ADD calls, average return is -1.7% vs -5.1% for the S&P 500 (+3.4% alpha).
SELL/REDUCE calls are shown as Correct, Incorrect, or Pending. Only BUY/ADD calls are compared directly against the S&P 500 in the ticker-level return stats.